We are live on ! Find out more
BWP

Baldwin Wealth Partners Portfolio holdings

AUM $1.53B
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+28.5%
3 Year Est. Return
+85.86%
5 Year Est. Return
+102.78%
10 Year Est. Return
+445.81%
AUM
$1.33B
AUM Growth
+$54.7M
Cap. Flow
-$41.9M
Cap. Flow %
-3.16%
Top 10 Hldgs %
36.44%
Holding
744
New
19
Increased
41
Reduced
249
Closed
48

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$13.3M
2
COST icon
Costco
COST
+$6.62M
3
URI icon
United Rentals
URI
+$4.09M
4
NVDA icon
NVIDIA
NVDA
+$3.1M
5
MSFT icon
Microsoft
MSFT
+$2.75M

Sector Composition

Rank Sector Weight
1 Technology 26.88%
2 Financials 12.55%
3 Healthcare 10.96%
4 Industrials 8.4%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOV icon
51
Dover
DOV
$28.3B
$7.07M 0.53%
39,880
-505
-1% -$81.3K
BRK.B icon
52
Berkshire Hathaway Class B
BRK.B
$1.12T
$6.88M 0.52%
16,354
-64
-0.4% -$25.2K
ON icon
53
ON Semiconductor
ON
$31.4B
$6.72M 0.51%
+91,300
New +$6.99M
VGIT icon
54
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$6.43M 0.48%
109,805
+14,751
+16% +$865K
BAC icon
55
Bank of America
BAC
$440B
$6.34M 0.48%
167,290
-7,904
-5% -$271K
NVO
56
Novo Nordisk
NVO
$196B
$6.28M 0.47%
48,897
-1,215
-2% -$145K
CRL icon
57
Charles River Laboratories
CRL
$11.3B
$6.06M 0.46%
22,377
+22,266
+20,059% +$5.32M
MSCI icon
58
MSCI
MSCI
$41.5B
$5.63M 0.42%
10,039
-522
-5% -$293K
PAYX icon
59
Paychex
PAYX
$42.2B
$5.1M 0.38%
41,496
-2,729
-6% -$331K
ROP icon
60
Roper Technologies
ROP
$38.8B
$5.03M 0.38%
8,960
-161
-2% -$87.8K
CF icon
61
CF Industries
CF
$18.1B
$4.84M 0.36%
58,159
-2,607
-4% -$208K
NVS icon
62
Novartis
NVS
$291B
$4.75M 0.36%
49,074
-1,433
-3% -$147K
ET icon
63
Energy Transfer Partners
ET
$70B
$4.52M 0.34%
287,129
-1,200
-0.4% -$17.5K
BND icon
64
Vanguard Total Bond Market
BND
$158B
$4.47M 0.34%
61,586
+579
+0.9% +$42K
AXSM icon
65
Axsome Therapeutics
AXSM
$10.9B
$3.97M 0.3%
49,695
+700
+1% +$58.8K
VRTX icon
66
Vertex Pharmaceuticals
VRTX
$121B
$3.75M 0.28%
8,982
-190
-2% -$80.3K
ADP icon
67
Automatic Data Processing
ADP
$108B
$3.59M 0.27%
14,376
-295
-2% -$72.1K
TMO icon
68
Thermo Fisher Scientific
TMO
$209B
$3.5M 0.26%
6,014
-1,271
-17% -$713K
SYK icon
69
Stryker
SYK
$129B
$3.47M 0.26%
9,702
-495
-5% -$167K
MKC icon
70
McCormick & Company Non-Voting
MKC
$14B
$3.33M 0.25%
43,350
-3,944
-8% -$268K
TD icon
71
Toronto Dominion Bank
TD
$197B
$3.31M 0.25%
54,833
-1,000
-2% -$60.4K
EOG icon
72
EOG Resources
EOG
$76.4B
$3.27M 0.25%
25,580
-827
-3% -$96.5K
MO icon
73
Altria Group
MO
$114B
$2.98M 0.22%
68,425
-6,907
-9% -$286K
PM icon
74
Philip Morris
PM
$291B
$2.96M 0.22%
32,323
-2,441
-7% -$225K
KO icon
75
Coca-Cola
KO
$372B
$2.94M 0.22%
48,128
-650
-1% -$39K

Similar funds

Baldwin Wealth Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Baldwin Wealth Partners held 744 positions worth $1.33B, up 4.3% from $1.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Baldwin Wealth Partners withdrew a net $41.9M in Q1 2024, closing 48 positions and reducing 249 holdings. Its most notable exit was Synaptics, an estimated $103K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Baldwin Wealth Partners opened a new position in ON Semiconductor worth $6.72M.

  • Baldwin Wealth Partners's largest Q1 2024 buy was ON Semiconductor: 91,300 shares worth $6.72M.
  • Baldwin Wealth Partners added most to Charles River Laboratories in Q1 2024, an estimated $5.32M increase.
  • Baldwin Wealth Partners's biggest Q1 2024 reduction was Humana, cutting an estimated $13.3M.
  • Baldwin Wealth Partners fully exited Synaptics in Q1 2024, selling an estimated $103K.
  • Baldwin Wealth Partners's ten largest holdings make up 36% of its $1.33B portfolio in Q1 2024.
  • Baldwin Wealth Partners opened 19 new positions and closed 48 in Q1 2024.
  • Baldwin Wealth Partners's portfolio value rose 4.3% quarter-over-quarter to $1.33B.

Based on Baldwin Wealth Partners's 13F filing for Q1 2024, filed 12 Apr 2024.